Objective To provide evidence-based recommendations regarding the diagnosis and
management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …

The initial presentation of non-alcoholic steatohepatitis (NASH) is hepatic steatosis. The
dysfunction of lipid metabolism within hepatocytes caused by genetic factors, diet, and …

This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty
liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and …

The global prevalence of nonalcoholic fatty liver disease (NAFLD) has dramatically
increased in parallel with the epidemic of obesity. Controversy has emerged around dietary …

Current cardiometabolic disease prevention guidelines recommend increasing dietary
unsaturated fat intake while reducing saturated fats. Here we use lipidomics data from a …

NAFLD is the world's most common chronic liver disease, and its increasing prevalence
parallels the global rise in diabetes and obesity. It is characterised by fat accumulation in the …

Adolescent polycystic ovary syndrome (PCOS) is a highly prevalent, reversible, endocrine-
metabolic mode essentially driven by ectopic fat, which, in turn, often results from a …

A healthy diet together with physical activity could induce weight loss and control the
progression of non‐alcoholic fatty liver disease (NAFLD). However, the composition of diet …

There is general agreement that the acute suppression of hepatic glucose production by
insulin is mediated by both a direct and an indirect effect on the liver. There is, however, no …

Ceramides are a heterogeneous group of bioactive membrane sphingolipids that play
specialized regulatory roles in cellular metabolism depending on their characteristic fatty …